S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

LHC Group Stock Forecast, Price & News

-3.50 (-3.05%)
(As of 12/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
354,400 shs
Average Volume
229,546 shs
Market Capitalization
$3.53 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive LHCG News and Ratings via Email

Sign-up to receive the latest news and ratings for LHC Group and its competitors with MarketBeat's FREE daily newsletter.

LHC Group logo

About LHC Group

LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including skilled nursing, private duty nursing, physical, occupational and speech therapy, medically-oriented social services and hospice care. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel by operating an institutional pharmacy, wh


See More Headlines

Industry, Sector and Symbol

Home health care services
Health Care Services
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$2.06 billion
Cash Flow
$6.54 per share
Book Value
$54.19 per share


Net Income
$111.60 million
Pretax Margin




Free Float
Market Cap
$3.53 billion

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)

Social Links


Overall MarketRank

2.20 out of 5 stars

Medical Sector

400th out of 1,388 stocks

Home Health Care Services Industry

7th out of 9 stocks

Analyst Opinion: 4.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

LHC Group (NASDAQ:LHCG) Frequently Asked Questions

Is LHC Group a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LHC Group stock.
View analyst ratings for LHC Group
or view top-rated stocks.

How has LHC Group's stock been impacted by Coronavirus?

LHC Group's stock was trading at $127.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LHCG stock has decreased by 12.3% and is now trading at $111.41.
View which stocks have been most impacted by COVID-19

When is LHC Group's next earnings date?

LHC Group is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for LHC Group

How were LHC Group's earnings last quarter?

LHC Group, Inc. (NASDAQ:LHCG) released its quarterly earnings results on Wednesday, November, 3rd. The health services provider reported $1.45 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $1.45. LHC Group had a trailing twelve-month return on equity of 11.07% and a net margin of 6.01%. During the same quarter last year, the business posted $1.63 EPS.
View LHC Group's earnings history

What guidance has LHC Group issued on next quarter's earnings?

LHC Group issued an update on its FY 2021 earnings guidance on Monday, November, 15th. The company provided earnings per share guidance of $5.750-$5.850 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.950. The company issued revenue guidance of $2.22 billion-$2.22 billion, compared to the consensus revenue estimate of $2.22 billion.

What price target have analysts set for LHCG?

10 brokerages have issued 12 month target prices for LHC Group's shares. Their forecasts range from $150.00 to $210.00. On average, they anticipate LHC Group's share price to reach $177.60 in the next twelve months. This suggests a possible upside of 59.4% from the stock's current price.
View analysts' price targets for LHC Group
or view top-rated stocks among Wall Street analysts.

Who are LHC Group's key executives?

LHC Group's management team includes the following people:
  • Keith G. Myers, Chairman & Chief Executive Officer
  • Joshua L. Proffitt, President
  • Dale G. Mackel, Chief Financial Officer, Secretary & Executive VP
  • Angie M. Begnaud, Chief Clinical Officer & Executive Vice President
  • Benjamin Doga, Lead Medical Director

What is Keith G. Myers' approval rating as LHC Group's CEO?

524 employees have rated LHC Group CEO Keith G. Myers on Glassdoor.com. Keith G. Myers has an approval rating of 87% among LHC Group's employees.

What other stocks do shareholders of LHC Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), NVIDIA (NVDA), Home Depot (HD), Cisco Systems (CSCO), Visa (V), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA), Chevron (CVX) and Intel (INTC).

What is LHC Group's stock symbol?

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

Who are LHC Group's major shareholders?

LHC Group's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (15.85%), Wellington Management Group LLP (10.36%), Invesco Ltd. (3.42%), Alliancebernstein L.P. (2.41%), Eaton Vance Management (2.11%) and BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp (2.11%). Company insiders that own LHC Group stock include Ronald T Nixon and W Earl Reed III.
View institutional ownership trends for LHC Group

Which institutional investors are selling LHC Group stock?

LHCG stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Hood River Capital Management LLC, Invesco Ltd., Royal Bank of Canada, Allianz Asset Management GmbH, Moody Aldrich Partners LLC, Victory Capital Management Inc., and Morgan Stanley.
View insider buying and selling activity for LHC Group
or view top insider-selling stocks.

Which institutional investors are buying LHC Group stock?

LHCG stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Fuller & Thaler Asset Management Inc., BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Eaton Vance Management, Laurus Investment Counsel Inc., Wellington Management Group LLP, Ensign Peak Advisors Inc, and Geneva Capital Management LLC.
View insider buying and selling activity for LHC Group
or or view top insider-buying stocks.

How do I buy shares of LHC Group?

Shares of LHCG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LHC Group's stock price today?

One share of LHCG stock can currently be purchased for approximately $111.41.

How much money does LHC Group make?

LHC Group has a market capitalization of $3.53 billion and generates $2.06 billion in revenue each year. The health services provider earns $111.60 million in net income (profit) each year or $4.15 on an earnings per share basis.

How many employees does LHC Group have?

LHC Group employs 30,000 workers across the globe.

When was LHC Group founded?

LHC Group was founded in 1994.

What is LHC Group's official website?

The official website for LHC Group is www.lhcgroup.com.

Where are LHC Group's headquarters?

LHC Group is headquartered at 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508.

How can I contact LHC Group?

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The health services provider can be reached via phone at (337) 233-1307, via email at [email protected], or via fax at 337-235-8037.

This page was last updated on 12/6/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.